Chem.
Pharm. Bull. In a series of studies, the authors have reported a method of particle size reduction by making use of the phase conversion from a solvate or adduct to the original medicinal compound. In the present study, adduct formation was attempted between anhydrous HF, which is known to be one of the most acidic substances, and four medicinal compounds (griseofulvin, sulfanilamide, theophylline and phenacemide). Thermal and other physicochemical properties of the HF adducts and the recovered medicinals were investigated by differential scanning calorimetry, thermogravimetry, X-ray powder diffractometry, infrared spectroscopy and microscopy. The HCl salt of sulfanilamide was prepared and its properties were determined for reference. scanning electron micrographs of samples obtained via the HF adducts and particle size distribution data are shown in Figs. 11, 12 and 13. From these results, it is clear that effective particle size reduction is possible.
Further, as is shown in Fig. 12(d) , the external appearance of crystals of phenacemide obtained from its anhydrous HF solution revealed agglomerates that consisted of primary fine particles, which may be formed via the HF adduct, although adduct formation of phenacemide could not be confirmed because of low stability.
Conclusion
Griseofulvin, sulfanilamide and theophylline were confirmed to form HF adducts having combining ratios of 1 : 1 (griseofulvin : HF), 1 : 2 (sulfanilamide : HF) and 1 : 3 and 1 : 2 (theophylline : HF). The mechanisms of HF adduct formation are supposed to involve hydrogen bonding or dipole-induced dipole interaction. The particle size of each medicinal was effectively reduced by formation of the HF adduct and subsequent desorption of HF.
